Anticoagulation therapy in dialysis patients with atrial fibrillation is associated with a lower incidence of all-cause mortality despite an increased risk of severe bleeding.
Does anticoagulation therapy reduce all-cause mortality in dialysis patients with atrial fibrillation?
Anticoagulation therapy in dialysis patients with AF is associated with lower all-cause mortality but higher severe bleeding risk, necessitating individualized treatment and careful monitoring.
Absolute Event Rate: 0% vs 0%
: In dialysis patients with AF, anticoagulation therapy is associated with an increased incidence of severe bleeding, but anticoagulation therapy is associated with a low incidence of all-cause mortality. Individualized anticoagulation therapy with careful bleeding monitoring is needed in dialysis patients with AF.
Kim et al. (Thu,) reported a other. Anticoagulation therapy in dialysis patients with atrial fibrillation is associated with a lower incidence of all-cause mortality despite an increased risk of severe bleeding.